Jounce Therapeutics, Inc. (JNCE) Social Stream
Jounce Therapeutics Inc (JNCE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Jounce Therapeutics Inc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Over the past 18 months, JNCE's average upside potential has been 68.66%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
JNCE Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
JNCE's average broker recommendation rating improved by 0.5 over the prior 20 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Jounce Therapeutics Inc's variance in analysts' estimates is lower than 87.82% of Pharmaceutical Products stocks.
- The average analyst price target of JNCE is greater than 18.4% of all US stocks.
- The number of analysts covering the stock of JNCE is greater than 79.6% of stocks in the small market cap category.
- Jounce Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 78.38% of all US stocks.
Is JNCE a Buy, Hold or Sell? See the POWR Ratings now!